Publications: DR Alastair Lamb

Soliman C, Sathianathen N, Corcoran NM, Wuethrich PY, Furrer MA, Collaborators CSG, Ali FA, Abu Ghanem Y et al. ( 2026 ) . International Multicentre Analysis of Perioperative Complications Following Major Urologic Oncologic Surgery: Early Results from More than 130 000 Procedures from the CAMUS Collaborative . European Urology Focus

Soliman C, Sathianathen NJ, Corcoran NM, Lawrentschuk N, Wuethrich PY, Furrer MA, Collaborators OBOTCSG, Ali FA et al. ( 2026 ) . The CAMUS Initiative: A Multiphase, Multicentre International Collaboration to Redefine Risk Stratification, Reporting, and Grading of Surgical Complications in Urology . European Urology Open Science vol. 87 , 57 - 70 .

Anbarasan T, Dichmont M, Figiel S, Papiez B, Lamb A, Bryant R, Mills I ( 2026 ) . Abstract 2621: A systematic review of radiogenomic applications in prostate cancer . Cancer Research vol. 86 , ( 7_Supplement ) 2621 - 2621 .

Anbarasan T, Figiel S, Beesley M, Yin W, McPherson R, Colling R, Hamdy F, Bryant RJ et al. ( 2026 ) . Abstract 2784: Integrating spatial transcriptomics with MRI reveals distinct radio-spatial genomic profile concordant with prostate cancer clonal heterogeneity . Cancer Research vol. 86 , ( 7_Supplement ) 2784 - 2784 .

Lamb AD, Lundeberg J, Figiel S, Beesley M, He M ( 2026 ) . Abstract 3539: Spatial profiling of prostate cancer clonal evolution linked to nodal metastases . Cancer Research vol. 86 , ( 7_Supplement ) 3539 - 3539 .

Ranasinha N, Lamb AD, Marian IR, Leslie TA, Catto JWF, Rosario DJ, Yamamoto H, Eddy B et al. ( 2026 ) . A0842 Comparison of prostate cancer yield per MRI target lesion for LATP versus TRUS prostate biopsy: New insights from the TRANSLATE randomised clinical trial . European Urology vol. 89 , s1 - s2 .

Sharma A, Campbell T, Kanabar S, Soanes H, Sathanapally G, Bates A, John R, Adams C et al. ( 2026 ) . The PRAGMATIC pathway ‐ PRostate cancer diAGnosis and MAnagement Triage In Clinical care . BJU International vol. 137 , ( 5 ) 849 - 857 .

Thorley N, Parry T, Brembilla G, Giganti F, Barrett T, Eldred-Evans D, Mayor N, Lamb A et al. ( 2026 ) . Diagnostic accuracy of a ‘stage-gated’ approach for reporting prostate screening MRI: “Is less more?” . European Radiology1 - 10 .

He M, Figiel S, Beesley M, Shi J, Yin W, Perisynaki E, Colling R, Mills IG et al. ( 2026 ) . Abstract PR013: Comprehensive spatial profiling of prostate cancer metastasis: Mapping clonal evolution, microenvironment dynamics, and early metastatic markers . Cancer Research vol. 86 , ( 2_Supplement ) pr013 - pr013 .

Doultsinos D, Tomljanovic I, Pilalis E, Abusamra S, Figiel S, Parmentier R, Bridges I, Hester J et al. ( 2026 ) . Abstract PR030: Integrating multi-omic datasets investigating stress response biology decodes prostate cancer dynamic disease progression and places IRE1 activity at the epicentre of acquired treatment resistance . Cancer Research vol. 86 , ( 2_Supplement ) pr030 - pr030 .

Abusamra SM, Anbarasan T, Cotton DT, Ranasinha NMS, Barber R, Bridge S, Smith C, Figiel S et al. ( 2026 ) . Circulating tumour cells as a window into lethality in prostate cancer . Nature Reviews Urology1 - 18 .

Little M, Wolstenholme J, Landeiro F, Marian IR, Williams R, Lopez JF, Mercader C, Raslan M et al. ( 2025 ) . Cost Effectiveness of Local Anaesthetic Transperineal Versus Transrectal Biopsy: Results from the TRANSLATE Study . European Urology Focus vol. 12 , ( 2 ) 227 - 236 .

Morlanes JE, Lehto T-P, Larsson L, Galicia LA, Mollbrink A, Shamikh A, Basmaci E, Prochazka G et al. ( 2025 ) . Surveying the molecular landscape of pediatric brain tumors via spatially resolved transcriptomics . Briefings in Bioinformatics vol. 26 , ( Supplement_1 ) i22 - i23 .

Dolgos R, Parmentier R, Wang J, Servant R, Templeton AJ, Zellweger T, Lamb AD, Mertz KD et al. ( 2025 ) . Single-cell analysis uncovers preserved prostate cancer lineages and universally altered pathways in Matrigel-free patient-derived organoids . Cell Reports vol. 44 , ( 10 )

Roperch J-P, Charbonnier G, Figiel S, Lamb A, Mills I, Hennion C, Cancel-Tassin G, Cussenot O ( 2025 ) . Multiple highly methylated CpG sites as potential epigenetic markers for the diagnosis of prostate cancer . Clinical Epigenetics vol. 17 , ( 1 )

Connor MJ, Shah TT, Sukumar J, Basak D, Fiorentino F, Heath C, Horan G, Johnson N et al. ( 2025 ) . Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial . European Urology Oncology vol. 9 , ( 2 ) 276 - 285 .

Kotecha P, Rajan P, Figiel S, Lamb AD ( 2025 ) . Screening for prostate cancer . The BMJ vol. 389 ,

Anbarasan T, Figiel S, Abusamra SM, Yin W, Ranasinha N, Grist JT, Woodcock DJ, Bryant RJ et al. ( 2025 ) . Abstract 3684: Integrating multiparametric MRI with spatial transcriptomics to identify “Radio-Spatial Genomic” features of prostate cancer using artificial intelligence . Cancer Research vol. 85 , ( 8_Supplement_1 ) 3684 - 3684 .

Dolgos R, Parmentier R, Wang J, Servant R, Templeton AJ, Zellweger T, Lamb A, Mertz K et al. ( 2025 ) . Abstract 5205: ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover in vitro-enriched cell types . Cancer Research vol. 85 , ( 8_Supplement_1 ) 5205 - 5205 .

Bryant RJ, Marian IR, Williams R, Lopez JF, Mercader C, Raslan M, Berridge C, Whitburn J et al. ( 2025 ) . Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial . The Lancet Oncology vol. 26 , ( 5 ) 583 - 595 .

Dolgos R, Parmentier R, Wang J, Servant R, Templeton AJ, Zellweger T, Lamb A, Mertz K et al. ( 2025 ) . A0165 – ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover in vitro-enriched cell types . European Urology vol. 87 ,

Cumberbatch M, North B, Kealy R, Smith S, Hubbard R, Kennish S, Bhattrai S, Chahal R et al. ( 2025 ) . Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study . BMJ Open vol. 15 , ( 2 )

Erickson A, Figiel S, Rajakumar T, Rao S, Yin W, Doultsinos D, Magnussen A, Singh R et al. ( 2025 ) . Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of epithelial cancers . PLOS ONE vol. 20 , ( 1 )

Lamb AD, Landeiro F, Marian IR, Tuck S, Bryant RJ ( 2024 ) . Evidence for local anaesthetic transperineal biopsy versus transrectal prostate biopsy . The BMJ vol. 387 ,

Abusamra S, Anbarasan T, Cotton D, Figiel S, Barber R, Yin W, Morgan T, Mills I et al. ( 2024 ) . Circulating tumour cell isolation and enrichment for investigation of prostate cancer metastasis . The Journal of Liquid Biopsy vol. 5 ,

Byrne MHV, Ranasinha N, Sharma A, Mercader C, Raslan M, Sathanapally G, Lewis F, Gorgoraptis S et al. ( 2024 ) . Flourine-18 Prostate-Specific Membrane Antigen-1007 Positron Emission Tomography Imaging in Staging of Primary and Secondary Prostate Cancer—A Retrospective Observational Cohort Study . JU Open Plus vol. 2 , ( 10 )

Figiel S, Bates A, Braun DA, Eapen R, Eckstein M, Manley BJ, Milowsky MI, Mitchell TJ et al. ( 2024 ) . Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology . European Urology vol. 87 , ( 1 ) 8 - 14 .

Anbarasan T, Raslan M, Ghosh K, Macklin P, Mercader C, Leslie T, Hamdy FC, Colling R et al. ( 2024 ) . Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10‐year single‐centre cohort . BJUI Compass vol. 5 , ( 9 ) 948 - 950 .

Desai TA, Hedman ÅK, Dimitriou M, Koprulu M, Figiel S, Yin W, Johansson M, Watts EL et al. ( 2024 ) . Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics . EBioMedicine vol. 105 ,

Marian IR, Ooms A, Holmes J, Parkes MJ, Lamb AD, Bryant RJ ( 2024 ) . Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial . Trials vol. 25 , ( 1 )

Hamdy FC, Lamb AD, Tullis IDC, Verrill C, Rombach I, Rao SR, Colling R, Barber PR et al. ( 2024 ) . First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy . European Journal of Nuclear Medicine and Molecular Imaging vol. 51 , ( 10 ) 3009 - 3025 .

López JF, Bryant RJ, Lamb AD ( 2024 ) . Biopsia prostática transperineal bajo anestesia local: una cohorte prospectiva en un centro y operador único . Revista Chilena de Urología vol. 89 , ( 1 ) 001 - 007 .

Bissala RP, Mercader C, Lamb A, Campbell M, López F, Leslie T, Miah S, Bell R et al. ( 2024 ) . AB001. SOH24AB_065. Ten top tips to be a good robotic assistant . Mesentery and Peritoneum vol. 8 , ( 0 ) ab001 - ab001 .

Ranasinha NM, Bates AS, Anbarasan T, Sharma A, Bryant RJ, Leslie T, Leiblich A, Lopez F et al. ( 2024 ) . MP52-09 EARLY RETURN TO CONTINENCE, ONCOLOGICAL SAFETY AND SIGNIFICANCE OF MEMBRANOUS URETHRAL LENGTH IN ANTERIOR RETZIUS SPARING ROBOT ASSISTED RADICAL PROSTATECTOMY (RARP) . Journal of Urology vol. 211 , ( 5S )

Figiel S, Yin W, He M, Teague R, Anbarasan T, Ranasinha N, Abusamra S, Singh R et al. ( 2024 ) . PD09-06 EXPLORING STROMAL DYNAMICS IN PROSTATE CANCER: INSIGHTS FROM SPATIAL TRANSCRIPTOMIC ANALYSES . Journal of Urology vol. 211 , ( 5S )

Anbarasan T, Yin W, Figiel S, Mills I, Lamb A ( 2024 ) . PD09-07 SPATIAL TRANSCRIPTOMIC SIGNATURE FROM MUTATED BENIGN ANCESTRAL CLONE PREDICTS HIGH RISK PROSTATE CANCER . Journal of Urology vol. 211 , ( 5S )

Yin W, Figiel S, He M, Teague R, Anbarasan T, Ranasinha N, Singh R, Poulose N et al. ( 2024 ) . PD09-08 SPATIAL TRANSCRIPTOMIC CLONAL DECONVOLUTION IDENTIFIES THE ‘LETHAL CLONE’ IN PROSTATE CANCER AS DEFINED BY ABILITY TO METASTASIZE TO LYMPH NODES . Journal of Urology vol. 211 , ( 5S )

Anbarasan T, Figiel S, Teague R, Yin W, Colling R, Verrill C, Mills I, Lamb A ( 2024 ) . V12-12 NOVEL METHODOLOGY FOR OPTIMISING FORMALIN FIXED PARAFFIN EMBEDDED PROSTATE CANCER SECTIONS FOR SPATIAL TRANSCRIPTOMICS ANALYSIS . Journal of Urology vol. 211 , ( 5S )

Charlton PV, O'Reilly D, Philippou Y, Rao SR, Lamb ADG, Mills IG, Higgins GS, Hamdy FC et al. ( 2024 ) . Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post‐radiotherapy, and those with de novo metastatic disease . The Prostate vol. 84 , ( 10 ) 977 - 990 .

Berridge C, Omer A, Lopez F, Bryant RJ, Lamb AD ( 2024 ) . Perspectives on technology – prostate cancer: is local anaesthetic transperineal prostate biopsy really better than transrectal biopsy? . BJU International vol. 134 , ( 2 ) 166 - 174 .

Desai TA, Hedman AK, Dimitriou M, Koprulu M, Figiel S, Yin W, Johansson M, Watts EL et al. ( 2024 ) . Abstract 7330: Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using mendelian randomization and tumor spatial transcriptomics . Cancer Research vol. 84 , ( 6_Supplement ) 7330 - 7330 .

Anbarasan T, Fiegel S, Yin W, Mills I, Lamb A ( 2024 ) . O266: Transcriptomic signature from spatially inferred histologically benign ancestral clone predicts high risk prostate cancer . British Journal of Surgery vol. 111 , ( Supplement_2 )

Yin W, Figiel S, He M, Teague R, Anbarasan T, Ranasinha N, Singh R, Poulouse N et al. ( 2024 ) . A0708 Spatial transcriptomic clonal deconvolution identifies the lethal clone in Prostate Cancer (PCa) as defined by ability to metastasize to lymph nodes . European Urology vol. 85 , s1668 - s1669 .

Rao S, Verrill C, Cerundolo L, Alham NK, Kaya Z, O’Hanlon M, Hayes A, Lambert A et al. ( 2024 ) . Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole-genome sequencing with histopathological features . Genome Medicine vol. 16 , ( 1 )

Figiel S, Cancel-Tassin G, Mills IG, Lamb AD, Fromont G, Cussenot O ( 2023 ) . Molecular Anatomy of Prostate Cancer and Its Implications in Active Surveillance and Early Intervention Strategies . Anatomia vol. 2 , ( 4 ) 300 - 319 .

Figiel S, Yin W, Doultsinos D, Erickson A, Poulose N, Singh R, Magnussen A, Anbarasan T et al. ( 2023 ) . Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures . Molecular Cancer vol. 22 , ( 1 )

Bissala RP, Mercader C, Raslan M, Campbell M, López F, Leslie T, Miah S, Bell R et al. ( 2023 ) . Video 14 10 top tips to be a good robotic assistant . European Urology Open Science vol. 55 ,

Rao SR, Protheroe A, Cerundolo L, Maldonado-Perez D, Browning L, Lamb AD, Bryant RJ, Mills IG et al. ( 2023 ) . Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types . International Journal of Molecular Sciences vol. 24 , ( 16 )

Cussenot O, Cancel‐Tassin G, Rao SR, Woodcock DJ, Lamb AD, Mills IG, Hamdy FC ( 2023 ) . Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice? . BJU International vol. 132 , ( 5 ) 472 - 484 .

Erickson A, He M, Berglund E, Marklund M, Mirzazadeh R, Schultz N, Kvastad L, Andersson A et al. ( 2023 ) . Abstract A051: The spatial landscape of clonal somatic copy number alterations in benign and malignant prostate epithelia . Cancer Research vol. 83 , ( 11_Supplement ) a051 - a051 .

Sharma AD, Lopez JF, Leiblich A, Leslie TA, Lamb AD ( 2023 ) . Re: Fifteen-year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer . European Urology vol. 84 , ( 2 ) 245 - 246 .

Anbarasan T, Raslan M, Ghosh K, Macklin P, Mercader C, Leslie T, Hamdy F, Colling R et al. ( 2023 ) . MP55-09 NATURAL HISTORY OF ATYPICAL SMALL ACINAR PROLIFERATION (ASAP): A 10-YEAR CONTEMPORARY SERIES . Journal of Urology vol. 209 , ( Supplement 4 )

Bryant RJ, Hamdy FC, Lamb AD ( 2023 ) . The Detection of Prostate Cancer With Magnetic Resonance Imaging-targeted Prostate Biopsies Is Superior With the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study. Letter . Journal of Urology vol. 209 , ( 4 ) 679 - 679 .

Bryant RJ, Yamamoto H, Eddy B, Kommu S, Narahari K, Omer A, Leslie T, Catto JWF et al. ( 2023 ) . Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique . BJU International vol. 131 , ( 6 ) 694 - 704 .

Pratsinis M, Müllhaupt G, Güsewell S, Betschart P, Zumstein V, Engeler D, Schmid H-P, Lamb AD et al. ( 2023 ) . Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia . World Journal of Urology vol. 41 , ( 4 ) 1125 - 1131 .

Cussenot O, Renard‐Penna R, Montagne S, Ondet V, Pilon A, Guechot J, Comperat E, Hamdy F et al. ( 2023 ) . Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic risk . BJU International vol. 131 , ( 6 ) 745 - 754 .

Anbarasan T, Raslan M, Ghosh K, Macklin P, Mercader C, Leslie T, Hamdy FC, Colling R et al. ( 2023 ) . A0288 Natural history of Atypical Small Acinar Proliferation (ASAP): A 10-year contemporary series . European Urology vol. 83 , s418 - s419 .

Figiel S, Yin W, Doultsinos D, Erickson A, Poulose N, Singh R, Magnussen A, He M et al. ( 2023 ) . A1235 Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring . European Urology vol. 83 , s1793 - s1794 .

Altan O, Lamb A, Hamdy FC ( 2023 ) . Localized prostate cancer . Challenging Cases in Urological Surgery , Oxford University Press (OUP)

Cussenot O, Cancel‐Tassin G, Comperat E, Benbouzid S, Lamb A ( 2022 ) . Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable? . BJU International vol. 130 , ( 5 ) 582 - 585 .

Marklund M, Schultz N, Friedrich S, Berglund E, Tarish F, Tanoglidi A, Liu Y, Bergenstråhle L et al. ( 2022 ) . Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones . Nature Communications vol. 13 , ( 1 )

Erickson A, He M, Berglund E, Marklund M, Mirzazadeh R, Schultz N, Kvastad L, Andersson A et al. ( 2022 ) . Spatially resolved clonal copy number alterations in benign and malignant tissue . Nature vol. 608 , ( 7922 ) 360 - 367 .

Erickson A, Berglund E, He M, Marklund M, Mirzazadeh R, Schultz N, Kvastad L, Andersson A et al. ( 2022 ) . Abstract 2171: The spatial landscape of clonal somatic mutations in benign and malignant tissue . Cancer Research vol. 82 , ( 12_Supplement ) 2171 - 2171 .

Erickson A, Berglund E, He M, Marklund M, Mirzazadeh R, Schultz N, Bergenstråhle L, Kvastad L et al. ( 2022 ) . Abstract PR016: The spatial landscape of clonal somatic mutations in benign and malignant tissue . Cancer Research vol. 82 , ( 10_Supplement ) pr016 - pr016 .

Rakovic K, Colling R, Browning L, Dolton M, Horton MR, Protheroe A, Lamb AD, Bryant RJ et al. ( 2022 ) . The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters . Diagnostics vol. 12 , ( 5 )

Byrne M, Ranasinha N, Mercader C, Raslan M, Lewis F, Gorgoraptis S, Sathanapally G, Vieira ACL et al. ( 2022 ) . MP51-13 FLUORINE-18 (18F) PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITRON EMISSION TOMOGRAPHY (PET) AND THE DIAGNOSIS AND STAGING OF PRIMARY PROSTATE CANCER (PCA) . Journal of Urology vol. 207 , ( Supplement 5 )

Byrne M, Ranasinha N, Mercader C, Raslan M, Gordon C, Hutton K, Head S, MacPherson R et al. ( 2022 ) . PD03-12 COVID-19 DISRUPTION TO PROSTATE CANCER MANAGEMENT IN A UK TERTIARY REFERRAL CENTRE . Journal of Urology vol. 207 , ( Supplement 5 )

Rahman B, Lamb A, Protheroe A, Shah K, Solomons J, Williams J, Ormondroyd E ( 2022 ) . Genomic sequencing in oncology: Considerations for integration in routine cancer care . European Journal of Cancer Care vol. 31 , ( 3 )

Miah S, Maw J, Pang K, Nair V, Hori S, Lamb A, Martin A, Bratt O et al. ( 2022 ) . The provision of prostate cancer patient information leaflets on an electronic tablet: A further step to paperless health-care provision . Urology Annals vol. 14 , ( 2 ) 156 - 161 .

Erickson AM, Berglund E, He M, Marklund M, Mirzazadeh R, Schultz N, Bergenstråhle L, Kvastad L et al. ( 2022 ) . A0480 The spatial landscape of clonal somatic mutations in benign and malignant prostate epithelia . European Urology vol. 81 , s725 - s726 .

Byrne MHV, Ranasinha N, Mercader C, Raslan M, Lewis F, Gorgoraptis S, Sathanapally G, Vieira ACL et al. ( 2022 ) . A0745 Fluorine-18 (18F) Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) and the diagnosis and staging of primary Prostate Cancer (PCa) . European Urology vol. 81 , s1105 - s1106 .

Barrull CM, Lopez JF, Ranasinha N, Raslan M, Macpherson R, Bell R, Leslie T, Bryant R et al. ( 2022 ) . V44 Varying approaches to the prostate apex to optimize urethral stability and early continence recovery after robotic radical prostatectomy . European Urology vol. 81 ,

Raslan M, Mercader C, Lamb AD ( 2022 ) . Re: Prostate Cancer Screening Using a Combination of Risk-prediction, MRI, and Targeted Prostate Biopsies (STHLM3-MRI): A Prospective, Population-based, Randomised, Open-label, Non-inferiority Trial . European Urology vol. 81 , ( 5 ) 543 - 544 .

Sooriakumaran P, Wilson C, Rombach I, Hassanali N, Aning J, Lamb AD, Cathcart P, Eden C et al. ( 2022 ) . Feasibility and safety of radical prostatectomy for oligo‐metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo‐Metastases to the bone (TRoMbone) trial . BJU International vol. 130 , ( 1 ) 43 - 53 .

Chelebian E, Avenel C, Kartasalo K, Marklund M, Tanoglidi A, Mirtti T, Colling R, Erickson A et al. ( 2021 ) . Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer . Cancers vol. 13 , ( 19 )

Taavitsainen S, Engedal N, Cao S, Handle F, Erickson A, Prekovic S, Wetterskog D, Tolonen T et al. ( 2021 ) . Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse . Nature Communications vol. 12 , ( 1 )

Yao M, Phelan C, Folkard S, Rajagopalan A, Varga B, Rusere J, Kommu SS, Lamb A et al. ( 2021 ) . MP30-18 ANTIBIOTIC FREE LOCAL ANAESTHETIC TRANSPERINEAL PROSTATE (LATP) BIOPSIES: A REVIEW OF THE FIRST 750 CASES . Journal of Urology vol. 206 , ( Supplement 3 ) e507 - e507 .

Sjoberg HT, Philippou Y, Magnussen AL, Tullis IDC, Bridges E, Chatrian A, Lefebvre J, Tam KH et al. ( 2021 ) . Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer . British Journal of Cancer vol. 125 , ( 4 ) 534 - 546 .

Carbonara U, Crocerossa F, Novara G, Ditonno P, Pansadoro V, Breda A, Rocco B, Cacciamani GE et al. ( 2021 ) . Risks and Benefits of Live Surgical Broadcast: A Systematic Review . European Urology Focus vol. 8 , ( 3 ) 870 - 881 .

Carbonara U, Novara G, Ditonno P, Battaglia M, Breda A, Crocerossa F, Rocco B, Kaouk J et al. ( 2021 ) . P0963 Risks and benefits of live surgery: A systematic review . European Urology vol. 79 ,

Erickson A, Hayes A, Rajakumar T, Verrill C, Bryant RJ, Hamdy FC, Wedge DC, Woodcock DJ et al. ( 2021 ) . A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease . European Urology Oncology vol. 4 , ( 3 ) 358 - 369 .

Schilling K, Moore RET, Sullivan KV, Capper MS, Rehkämper M, Goddard K, Ion C, Coombes RC et al. ( 2021 ) . Zinc stable isotopes in urine as diagnostic for cancer of secretory organs . Metallomics vol. 13 , ( 5 )

Lopez JF, Campbell A, Omer A, Stroman L, Bondad J, Austin T, Reeves T, Phelan C et al. ( 2021 ) . Local anaesthetic transperineal (LATP) prostate biopsy using a probe‐mounted transperineal access system: a multicentre prospective outcome analysis . BJU International vol. 128 , ( 3 ) 311 - 318 .

Chow K, Bedő J, Ryan A, Agarwal D, Bolton D, Chan Y, Dundee P, Frydenberg M et al. ( 2021 ) . Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival . European Journal of Cancer vol. 148 , 440 - 450 .

Rajakumar T, Yassin M, Musbahi O, Harris E, Lopez JF, Bryant RJ, Tullis ID, Vojnovic B et al. ( 2021 ) . Use of intraoperative fluorescence to enhance robot-assisted radical prostatectomy . Future Oncology vol. 17 , ( 9 ) 1083 - 1095 .

Ranasinha N, Omer A, Philippou Y, Harriss E, Davies L, Chow K, Chetta PM, Erickson A et al. ( 2021 ) . Ductal adenocarcinoma of the prostate: A systematic review and meta‐analysis of incidence, presentation, prognosis, and management . BJUI Compass vol. 2 , ( 1 ) 13 - 23 .

Charlton P, O'Reilly D, Philippou Y, Rao S, Lamb A, Higgins G, Hamdy F, Verrill C et al. ( 2020 ) . PO-1160: A pilot dual-platform transcriptomic analysis of diagnostic prostate biopsies & radical RT response . Radiotherapy and Oncology vol. 152 , s610 - s611 .

Stroman L, Cathcart P, Lamb A, Challacombe B, Popert R ( 2020 ) . A cross‐section of UK prostate cancer diagnostics during the coronavirus disease 2019 (COVID‐19) era – a shifting paradigm? . BJU International vol. 127 , ( 1 ) 30 - 34 .

Lopez F, Macpherson R, Lamb A ( 2020 ) . Editorial Comment . Journal of Urology vol. 204 , ( 4 )

Philippou Y, Sjoberg HT, Murphy E, Alyacoubi S, Jones KI, Gordon-Weeks AN, Phyu S, Parkes EE et al. ( 2020 ) . Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model . British Journal of Cancer vol. 123 , ( 7 ) 1089 - 1100 .

Philippou Y, Campbell A, Leiblich A, Brewster S, Bell RW, Bryant RJ, Leslie T, Hamdy FC et al. ( 2020 ) . 272 A lesion specific analysis of the performance of multiparametric MRI in detection of clinically significant prostate cancer in the PART feasibility trial . European Urology Open Science vol. 19 ,

Charlton P, O’Reilly D, Philippou Y, Rao S, Lamb AD, Higgins G, Hamdy FC, Verrill C et al. ( 2020 ) . 350 A pilot transcriptomic analysis of archival prostate biopsy samples and response to radical radiotherapy . European Urology Open Science vol. 19 ,

Erickson AM, Hayes A, Lovegrove C, Vesty-Edwards L, Woodcock D, Bryant RJ, Hamdy F, Wedge DC et al. ( 2020 ) . 409 Harnessing the power of RNA in determining the origin of lethal micro-metastatic prostate cancer . European Urology Open Science vol. 19 ,

Philippou Y, Sjoberg H, Murphy E, Alyacoubi S, Jones K, Gordon-Weeks AN, Lamb AD, McKenna WG et al. ( 2020 ) . PT078 Investigating tumour immune microenvironment effects of hypofractionated radiotherapy +/- immune checkpoint blockade in immunocompetent pre-clinical prostate cancer models . European Urology Open Science vol. 19 ,

Lovegrove C, Musbahi O, Ranasinha N, Omer A, Campbell A, Bryant R, Leslie T, Bell R et al. ( 2020 ) . PT211 Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit: The “Fry-Turnbull” effect . European Urology Open Science vol. 19 , e2005 - e2006 .

Sathianathen NJ, Thangasamy I, Lane R, Condon B, Murphy DG, Lawrentschuk N, Weight CJ, Lamb AD ( 2020 ) . Corrigendum to “Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score” [Eur Urol Focus 6 (2020) 458–62] . European Urology Focus vol. 7 , ( 3 )

Sathianathen NJ, Omer A, Harriss E, Davies L, Kasivisvanathan V, Punwani S, Moore CM, Kastner C et al. ( 2020 ) . Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis . European Urology vol. 78 , ( 3 ) 402 - 414 .

Philippou Y, Sjoberg H, Lamb AD, Camilleri P, Bryant RJ ( 2020 ) . Harnessing the potential of multimodal radiotherapy in prostate cancer . Nature Reviews Urology vol. 17 , ( 6 ) 321 - 338 .

Sathianathen NJ, Lane R, Murphy DG, Loeb S, Bakker C, Lamb AD, Weight CJ ( 2020 ) . Social Media Coverage of Scientific Articles Immediately After Publication Predicts Subsequent Citations - #SoME_Impact Score: Observational Analysis . Journal of Medical Internet Research vol. 22 , ( 4 )

Ranasinha* NMS, Omer A, Harriss E, Davies L, Chow K, Chetta PM, Erickson A, Mills IG et al. ( 2020 ) . MP67-19 DUCTAL ADENOCARCINOMA OF THE PROSTATE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INCIDENCE, PRESENTATION AND MANAGEMENT . Journal of Urology vol. 203 , ( Supplement 4 )

Rao SR, Alham NK, Upton E, McIntyre S, Bryant RJ, Cerundolo L, Bowes E, Jones S et al. ( 2020 ) . Detailed Molecular and Immune Marker Profiling of Archival Prostate Cancer Samples Reveals an Inverse Association between TMPRSS2:ERG Fusion Status and Immune Cell Infiltration . Journal of Molecular Diagnostics vol. 22 , ( 5 ) 652 - 669 .

Tan J-L, Lamb A, Prall O, West C, Goad J, Lawrentschuk N ( 2020 ) . Anterior prostatectomy for the excision of bladder paraganglioma with prostatic invasion: a unique case of partial prostatectomy . Australian and New Zealand Journal of Surgery vol. 90 , ( 10 ) 2131 - 2133 .

Lovegrove CE, Musbahi O, Ranasinha N, Omer A, Lopez F, Campbell A, Bryant RJ, Leslie T et al. ( 2020 ) . Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit – the ‘Fry‐Turnbull’ effect . BJU International vol. 125 , ( 4 ) 484 - 486 .

Grummet J, Gorin MA, Popert R, O’Brien T, Lamb AD, Hadaschik B, Radtke JP, Wagenlehner F et al. ( 2020 ) . “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now . Prostate Cancer and Prostatic Diseases vol. 23 , ( 1 ) 62 - 65 .

Schilling K, Halliday A, Lamb A, Cronogorac-Jurcevic T, Larner F ( 2020 ) . Urinary Zinc Stable Isotope Signature as Indicator for Cancer Types with Disrupted Zinc Metabolism . Conference: Goldschmidt Abstracts2305 - 2305 .

Sathianathen NJ, Lane R, Condon B, Murphy DG, Lawrentschuk N, Weight CJ, Lamb AD ( 2019 ) . Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_Score . European Urology Focus vol. 6 , ( 3 ) 458 - 462 .

Omer A, Lamb AD ( 2019 ) . Optimizing prostate biopsy techniques . Current Opinion in Urology vol. 29 , ( 6 ) 578 - 586 .

Wu X, Scott H, Carlsson SV, Sjoberg DD, Cerundolo L, Lilja H, Prevo R, Rieunier G et al. ( 2019 ) . Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy . The Prostate vol. 79 , ( 10 ) 1079 - 1089 .

Philippou Y, Harriss E, Davies L, Jubber I, Leslie T, Bell RW, Bryant RJ, Hamdy FC et al. ( 2019 ) . Prostatic capsular incision during radical prostatectomy has important oncological implications: a systematic review and meta‐analysis . BJU International vol. 124 , ( 4 ) 554 - 566 .

Campbell* A, Omer A, Stroman L, Leiblich A, Philippou Y, Musbahi O, Ranasinha N, Bryant RJ et al. ( 2019 ) . MP24-16 LOCAL ANAESTHETIC TRANSPERINEAL PROSTATE (LATP) BIOPSY USING THE PRECISION POINT ACCESS SYSTEM: A MULTI-CENTRE OUTCOME ANALYSIS . Journal of Urology vol. 201 , ( Supplement 4 )

Sathianathen* N, Omer A, Moore C, Kasivisvanathan V, van den Bergh R, Punwani S, Kastner C, Barrett T et al. ( 2019 ) . MP24-19 NEGATIVE PREDICTIVE VALUE OF MULTI-PARAMETRIC MRI IN DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS . Journal of Urology vol. 201 , ( Supplement 4 )

Sooriakumaran* P, Rajan P, Al Kadhi O, Kelly J, Aning J, Soomro N, Bryant R, Lamb A et al. ( 2019 ) . PD15-09 TROMBONE: TESTING RADICAL PROSTATECTOMY IN MEN WITH OLIGOMETASTATIC PROSTATE CANCER THAT HAS SPREAD TO THE BONE- A RANDOMIZED CONTROLLED FEASIBILITY TRIAL . Journal of Urology vol. 201 , ( Supplement 4 )

Sathianathen NJ, Philippou YA, Kuntz GM, Konety BR, Gupta S, Lamb AD, Dahm P ( 2019 ) . Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer: a Cochrane Review . BJU International vol. 124 , ( 3 ) 370 - 372 .

Sathianathen N, Lane R, Murphy DG, Loeb S, Bakker C, Lamb AD, Weight CJ ( 2019 ) . 632 Social media coverage of scientific articles immediately after publication predicts subsequent citations: #SoMe_Impact Score . European Urology Open Science vol. 18 , ( 1 )

Sathianathen N, Omer A, Kasivisvanathan V, Punwani S, Moore C, Kastner C, Barrett T, Van Den Bergh R et al. ( 2019 ) . PT112 Negative predictive value of multi-parametric MRI in detection of clinically significant prostate cancer: A systematic review and meta-analysis . European Urology Open Science vol. 18 , ( 1 )

Sooriakumaran P, Rajan P, Al Kadhi O, Kelly J, Aning J, Soomro N, Bryant R, Lamb A et al. ( 2019 ) . PT390 TRoMbone: Testing radical prostatectomy in men with oligo metastatic prostate cancer that has spread to the bone - a randomized controlled feasibility trial . European Urology Open Science vol. 18 , ( 1 )

Bakht MK, Derecichei I, Li Y, Ferraiuolo R-M, Dunning M, Oh SW, Hussein A, Youn H et al. ( 2018 ) . Neuroendocrine differentiation of prostate cancer leads to PSMA suppression . Endocrine Related Cancer vol. 26 , ( 2 ) 131 - 146 .

Bratt O, Lamb AD ( 2018 ) . Genetic Reasons to Walk the Extra Mile to Prevent Prostate Cancer . European Urology vol. 76 , ( 1 ) 41 - 42 .

Sathianathen NJ, Philippou YA, Kuntz GM, Konety BR, Gupta S, Lamb AD, Dahm P ( 2018 ) . Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer . Cochrane Database of Systematic Reviews vol. 2018 , ( 10 )

Yang L, Roberts D, Takhar M, Erho N, Bibby BAS, Thiruthaneeswaran N, Bhandari V, Cheng W-C et al. ( 2018 ) . Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer . EBioMedicine vol. 31 , 182 - 189 .

Lamb AD, Bryant RJ, Mills IG, Hamdy FC ( 2018 ) . First Report of Prostate-specific Membrane Antigen–targeted Immunotherapy in Prostate Cancer: The Future is Bright . European Urology vol. 73 , ( 5 ) 653 - 655 .

Jurmeister S, Ramos‐Montoya A, Sandi C, Pértega‐Gomes N, Wadhwa K, Lamb AD, Dunning MJ, Attig J et al. ( 2018 ) . Identification of potential therapeutic targets in prostate cancer through a cross‐species approach . EMBO Molecular Medicine vol. 10 , ( 3 )

Tan J-L, Sathianathen N, Geurts N, Nair R, Murphy DG, Lamb AD ( 2017 ) . Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective . Urological Science vol. 28 , ( 4 ) 190 - 196 .

Hamdy FC, Lamb AD, Bryant RJ ( 2017 ) . Diagnostic Pathways for Screen-detected Prostate Cancer: The Plot Thickens . European Urology vol. 73 , ( 3 ) 351 - 352 .

Lamb AD, Bryant RJ, Camilleri P, Hamdy FC ( 2017 ) . Orient Expression: Solving the Mystery of Asian Prostate Cancer? . European Urology vol. 73 , ( 3 ) 340 - 342 .

Bellangino M, Verrill C, Leslie T, Bell RW, Hamdy FC, Lamb AD ( 2017 ) . Systematic Review of Studies Reporting Positive Surgical Margins After Bladder Neck Sparing Radical Prostatectomy . Current Urology Reports vol. 18 , ( 12 )

Lamb AD, Brewster SF, Hamdy FC ( 2017 ) . Reducing Mortality in the Ageing Patient: Treatment of the Primary Tumour Is Not Necessary . European Urology Focus vol. 3 , ( 4-5 ) 328 - 329 .

Sathianathen NJ, Philippou YA, Kuntz GM, Konety BR, Lamb AD, Dahm P ( 2017 ) . Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer . Cochrane Database of Systematic Reviews vol. 2017 , ( 9 )

Sathianathen NJ, Lamb AD, Lawrentschuk NL, Goad JR, Peters J, Costello AJ, Murphy DG, Moon DA ( 2017 ) . Changing face of robot‐assisted radical prostatectomy in Melbourne over 12 years . Australian and New Zealand Journal of Surgery vol. 88 , ( 3 ) e200 - e203 .

Lamb AD, Thompson S, Kinsella N, Gerbitz I, Chapman E, Putt L, Bennett S, Thankappannair V et al. ( 2017 ) . Corrigendum to “Aiming for a holistic integrated service for men diagnosed with prostate cancer – Definitions of standards and skill sets for nurses and allied healthcare professionals” [Eur. J. Oncol. Nurs. 29 (2017) 31–38] . European Journal of Oncology Nursing vol. 30 ,

Sathianathen NJ, Geurts N, Nair R, Lawrentschuk N, Murphy DG, Lamb AD ( 2017 ) . The phytological future of prostate cancer staging: PSMA-PET and the dandelion theory . Future Oncology vol. 13 , ( 20 ) 1801 - 1807 .

Geurts N, Lamb AD, Lawrentschuk N, Murphy DG ( 2017 ) . Prostate‐specific membrane antigen radioguided surgery: a promising utility . BJU International vol. 120 , ( 1 ) 5 - 6 .

Lamb AD, Thompson S, Kinsella N, Gerbitz I, Chapman E, Putt L, Bennett S, Thankappannair V et al. ( 2017 ) . Aiming for a holistic integrated service for men diagnosed with prostate cancer – Definitions of standards and skill sets for nurses and allied healthcare professionals . European Journal of Oncology Nursing vol. 29 , 31 - 38 .

Bozin M, Lamb A, Putra LJ ( 2017 ) . Pheochromocytoma with Negative Metanephrines: A Rarity and the Significance of Dopamine Secreting Tumors . Urology Case Reports vol. 12 , 51 - 53 .

Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, Egevad LA, Russell R et al. ( 2017 ) . Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144] . EBioMedicine vol. 17 ,

Luca B-A, Brewer DS, Edwards DR, Edwards S, Whitaker HC, Merson S, Cooper RA, Hazell S et al. ( 2017 ) . DESNT: A Poor Prognosis Category of Human Prostate Cancer . European Urology Focus vol. 4 , ( 6 ) 842 - 850 .

Dunning MJ, Vowler SL, Lalonde E, Ross-Adams H, Boutros P, Mills IG ( 2017 ) . Mining Human Prostate Cancer Datasets: The “camcAPP” Shiny App . EBioMedicine vol. 17 , 5 - 6 .

Johnston T, Lamb A, Vowler S, Xiong T, Moore A, Holding P, Herbert P, Davis M et al. ( 2017 ) . 234 An evaluation of a selective prostate cancer screening program using family history as a supplementary screening tool to PSA: Results from the ProtecT trial . European Urology Open Science vol. 16 , ( 3 ) e404 - e405 .

Kapoor J, Lamb AD, Murphy DG ( 2017 ) . Re: Diagnostic Accuracy of Multi-parametric MRI and TRUS Biopsy in Prostate Cancer (PROMIS): A Paired Validating Confirmatory Study . European Urology vol. 72 , ( 1 )

Lamb AD, Lawrence MG, Sandhu S ( 2017 ) . Practical Polling for Prostate Cancer: AR-V7–based Treatment Selection . European Urology vol. 71 , ( 6 ) 883 - 885 .

Sathianathen NJ, Lamb A, Nair R, Geurts N, Mitchell C, Lawrentschuk NL, Moon DA, Murphy DG ( 2016 ) . Updates of prostate cancer staging: Prostate-specific membrane antigen . Investigative and Clinical Urology vol. 57 , ( Suppl 2 ) s147 - s154 .

Lalonde E, Alkallas R, Chua MLK, Fraser M, Haider S, Meng A, Zheng J, Yao CQ et al. ( 2016 ) . Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors . European Urology vol. 72 , ( 1 ) 22 - 31 .

Ross-Adams H, Ball S, Lawrenson K, Halim S, Russell R, Wells C, Strand SH, Ørntoft TF et al. ( 2016 ) . HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer . Oncotarget vol. 5 , ( 0 ) 74734 - 74746 .

Johnston TJ, Shaw GL, Lamb AD, Parashar D, Greenberg D, Xiong T, Edwards AL, Gnanapragasam V et al. ( 2016 ) . Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial . European Urology vol. 71 , ( 3 ) 381 - 388 .

Zargar H, Lamb AD, Rocco B, Porpiglia F, Liatsikos E, Davis J, Coelho RF, Pow-Sang JM et al. ( 2016 ) . Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis . Minerva Urologica e Nefrologica vol. 69 , ( 1 ) 26 - 37 .

Thomas BC, Kay JD, Menon S, Vowler SL, Dawson SN, Bucklow LJ, Luxton HJ, Johnston T et al. ( 2016 ) . Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel . Endocrine Related Cancer vol. 23 , ( 10 ) 797 - 812 .

Lamb AD, Zargar H, Murphy DG, Corcoran NM, Hovens CM ( 2016 ) . Disrupting the Status Quo in Prostate Cancer Diagnosis . European Urology vol. 71 , ( 2 ) 193 - 194 .

Gnanapragasam VJ, Thurtle D, Srinivasan A, Volanis D, George A, Lophatananon A, Stearn S, Warren AY et al. ( 2016 ) . Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre . BJU International vol. 118 , ( 5 ) 779 - 784 .

Whitington T, Gao P, Song W, Ross-Adams H, Lamb AD, Yang Y, Svezia I, Klevebring D et al. ( 2016 ) . Gene regulatory mechanisms underpinning prostate cancer susceptibility . Nature Genetics vol. 48 , ( 4 ) 387 - 397 .

Johnston T, Shaw G, Lamb A, Gnanapragasam V, Greenberg D, Parashar D, Xiong T, Moore A et al. ( 2016 ) . 95 Detection of asymptomatic locally advanced and high-risk prostate cancer through PSA testing: Clinical outcomes in men excluded from the ProtecT Trial . European Urology Open Science vol. 15 , ( 3 )

Ross-Adams H, Lamb AD ( 2016 ) . The genetic classification of prostate cancer: whats on the horizon? . Future Oncology vol. 12 , ( 6 ) 729 - 733 .

Nelson AW, Lamb AD, Gnanapragasam VJ ( 2016 ) . Applying for research funding. Part 2 – Writing a grant application . Journal of Clinical Urology vol. 9 , ( 4 ) 230 - 233 .

Asim M, Massie CE, Orafidiya F, Pértega-Gomes N, Warren AY, Esmaeili M, Selth LA, Zecchini HI et al. ( 2015 ) . Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target . Journal of the National Cancer Institute vol. 108 , ( 5 )

Shaw GL, Whitaker H, Corcoran M, Dunning MJ, Luxton H, Kay J, Miller JL, Lamb AD et al. ( 2015 ) . The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer . European Urology vol. 70 , ( 2 ) 214 - 218 .

Lamb AD, Bratt O ( 2015 ) . Towards “next-generation” prostate cancer screening . The Lancet Oncology vol. 16 , ( 16 ) 1579 - 1580 .

Ross-Adams H, Lamb AD, Dunning MJ, Halim S, Lindberg J, Massie CM, Egevad LA, Russell R et al. ( 2015 ) . Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study . EBioMedicine vol. 2 , ( 9 ) 1133 - 1144 .

Massie CE, Spiteri I, Ross-Adams H, Luxton H, Kay J, Dunning MJ, Lamb AD, Ramos-Montoya A et al. ( 2015 ) . HES5 silencing is an early and recurrent change in prostate tumourigenesis . Endocrine Related Cancer vol. 22 , ( 2 ) 131 - 144 .

Lalonde E, Ishkanian AS, Sykes J, Fraser M, Ross-Adams H, Erho N, Dunning MJ, Halim S et al. ( 2014 ) . Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study . The Lancet Oncology vol. 15 , ( 13 ) 1521 - 1532 .

Sharma NL, Massie CE, Butter F, Mann M, Bon H, Ramos-Montoya A, Menon S, Stark R et al. ( 2014 ) . The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer . Nucleic Acids Research vol. 42 , ( 10 ) 6256 - 6269 .

Ramos‐Montoya A, Lamb AD, Russell R, Carroll T, Jurmeister S, Galeano‐Dalmau N, Massie CE, Boren J et al. ( 2014 ) . HES6 drives a critical AR transcriptional programme to induce castration‐resistant prostate cancer through activation of an E2F1‐mediated cell cycle network . EMBO Molecular Medicine vol. 6 , ( 5 ) 651 - 661 .

Lamb AD, Ramos-Montoya A, Russell R, Carroll T, Massie CE, Shaw G, Sharma NL, Warren AY et al. ( 2014 ) . 836 Hes6 drives a critical androgen receptor (AR) transcriptional program to induce castration resistant prostate cancer (CRPC) through activation of an E2F1-mediated cell cycle network . European Urology Open Science vol. 13 , ( 1 )

Lamb AD, Massie CE, Neal DE ( 2014 ) . The transcriptional programme of the androgen receptor (AR) in prostate cancer . BJU International vol. 113 , ( 3 ) 358 - 366 .

Lamb AD, Ramos-Montoya A, Russell R, Carroll T, Massie CE, Shaw GL, Sharma NL, Warren AY et al. ( 2014 ) . Role of Hes6 in castration-resistant prostate cancer . The Lancet vol. 383 ,

Robinson JLL, Hickey TE, Warren AY, Vowler SL, Carroll T, Lamb AD, Papoutsoglou N, Neal DE et al. ( 2013 ) . Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype . Oncogene vol. 33 , ( 50 ) 5666 - 5674 .

Lamb AD ( 2013 ) . Editorial Comment to White blood cell count is positively associated with benign prostatic hyperplasia . International Journal of Urology vol. 21 , ( 3 ) 312 - 312 .

Lamb AD, Neal DE ( 2013 ) . Role of the androgen receptor in prostate cancer . Trends in Urology & Men's Health vol. 4 , ( 3 ) 26 - 30 .

Sharma NL, Massie CE, Ramos-Montoya A, Zecchini V, Scott HE, Lamb AD, MacArthur S, Stark R et al. ( 2012 ) . The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man . Cancer Cell vol. 23 , ( 1 ) 35 - 47 .

Lamb A ( 2012 ) . Fast Facts: Prostate Cancer, seventh edition . BJU International vol. 110 , ( 3 ) e157 - e157 .

Johnston R, Finch WJG, Lamb A, Shaida N, Shah NC, Wiseman OJ ( 2011 ) . E165 Stone volume – what should we be measuring? . European Urology Open Science vol. 10 , ( 7 )

Finch WJG, Johnston R, Lamb A, Shaida N, Shah N, Wiseman O ( 2011 ) . Stone Volume—What Should We Be Measuring? . Journal of Clinical Urology vol. 4 , ( 5 ) 222 - 223 .

Lamb AD, Qadan M, Roberts S, Timlin H, Vowler SL, Campbell FM, Grigor K, Bartlett JMS et al. ( 2011 ) . CD4+ and CD8+ T‐lymphocyte scores cannot reliably predict progression in patients with benign prostatic hyperplasia . BJU International vol. 108 , ( 2b ) e43 - e50 .

Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ ( 2011 ) . Meta‐analysis showing the beneficial effect of α‐blockers on ureteric stent discomfort . BJU International vol. 108 , ( 11 ) 1894 - 1902 .

Lamb AD, Warren AY, Neal DE ( 2010 ) . Pre-malignant Disease in the Prostate . Pre-Invasive Disease: Pathogenesis and Clinical Management , Springer Nature

Lamb AD, Dunn N, Wiseman OJ ( 2010 ) . Meta-Analysis Demonstrating Beneficial Effect of Alpha Blockers on Ureteric Stent Discomfort . Journal of Clinical Urology vol. 3 , ( 3 ) 130 - 130 .

Lamb AD ( 2009 ) . Reply . Surgeon vol. 7 , ( 6 )

Dunn N, Lamb A ( 2009 ) . How effective is self‐management for men with lower urinary tract symptoms? . Trends in Urology Gynaecology & Sexual Health vol. 14 , ( 5 ) 4 - 5 .

Lamb AD, Wines MD, Mousa S, Tolley DA ( 2008 ) . Plain radiography still is required in the planning of treatment for urolithiasis: Editorial comment . vol. 34 , is. 6 ,

Lamb ADG, Wines MD, Mousa S, Tolley DA ( 2008 ) . Plain Radiography Still Is Required in the Planning of Treatment for Urolithiasis . Journal of Endourology . vol. 22 , 2201 - 2206 .

Wines MP, Lamb A, Argyropoulos AN, Caviezel A, Gannicliffe C, Tolley D ( 2008 ) . Blood Splash Injury: An Underestimated Risk in Endourology . Journal of Endourology vol. 22 , ( 6 ) 1183 - 1188 .

Lamb ADG, Qadan M, Gray AJ ( 2007 ) . Detection of occult pneumothoraces in the significantly injured adult with blunt trauma . European Journal of Emergency Medicine vol. 14 , ( 2 ) 65 - 67 .

Mariappan P, Smith G, Lamb ADG, Grigor KM, Tolley DA ( 2007 ) . Pattern of Recurrence Changes in Noninvasive Bladder Tumors Observed During 2 Decades . Journal of Urology vol. 177 , ( 3 ) 867 - 875 .

Lamb ADG, Robson AJ, Nixon SJ ( 2006 ) . Recurrence after totally extraperitoneal laparoscopic repair: Implications for operative technique and surgical training . The Surgeon vol. 4 , ( 5 ) 299 - 307 .

Erickson A, Figiel S, Rajakumar T, Rao S, Yin W, Doultsinos D, Magnussen A, Singh R et al. . Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of cancer .

Dolgos R, Parmentier R, Wang J, Servant R, Templeton AJ, Zellweger T, Lamb AD, Mertz KD et al. . ECM-free patient-derived organoids preserve diverse prostate cancer lineages and uncover in vitro-enriched cell types .

Doultsinos D, Tomljanovic I, Pilalis E, Abusamra S, Parmentier R, Bridges IE, Figiel S, Zekri Y et al. . IRE1 activity regulates tumour and microenvironment cell lineage states while stratifying localised and metastatic prostate cancer .

Desai TA, Hedman ÅK, Dimitriou M, Koprulu M, Figiel S, Yin W, Johansson M, Watts EL et al. . Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics .

Rao S, Verrill C, Cerundolo L, Alham NK, Kaya Z, O’Hanlon M, Hayes A, Lambert A et al. . Intra-prostatic tumour evolution, steps in metastatic spread and histogenomic associations revealed by integration of multi-region whole genome sequencing with histopathological features .

Dunning MJ, Vowler SL, Lalonde E, Ross-Adams H, Mills IG, Lynch AG, Lamb AD . Mining human prostate cancer datasets: The “camcAPP” shiny app .

Charlton P, O’Reilly D, Philippou Y, Rao, Lamb A, Mills I, Higgins G, Hamdy F et al. . Molecular analysis of archival diagnostic prostate cancer biopsies identifies genomic similarities in cases with progression post-radiotherapy, and those with de novo metastatic disease .

Pierre-Roperch J, Charbonnier G, Figiel S, Lamb AD, Mills I, Hennion C, Cancel-Tassin G, Cussenot O . Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate Cancer .

Sharma A, Campbell T, Bates A, John R, Adams C, Brassill A, Lennon B, Camilleri P et al. . PRAGMATIC - PRostate cancer diAGnosis and MAnagement – Triage In the Clinical care pathway .

Byrne MHV, Ranasinha N, Bryant RJ, Hamdy FC, Leslie T, Miah S, Gleeson F, MacPherson R et al. . Protocol for 18F-PSMA PET imaging in staging and management of prostate cancer – a retrospective cohort study .

Taavitsainen S, Engedal N, Cao S, Handle F, Erickson A, Prekovic S, Wetterskog D, Tolonen T et al. . Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer .

Sathianathen NJ, Lane III R, Murphy DG, Loeb S, Bakker C, Lamb AD, Weight CJ . Social Media Coverage of Scientific Articles Immediately After Publication Predicts Subsequent Citations - #SoME_Impact Score: Observational Analysis (Preprint) .

Figiel S, Yin W, Doultsinos D, Erickson A, Poulose N, Singh R, Magnussen A, Anbarasan T et al. . Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring .

Marian IR, Ooms A, Holmes J, Parkes MJ, Lamb AD, Bryant RJ . Statistical analysis plan for the TRANSLATE (TRANSrectal biopsy versus Local Anaesthetic Transperineal biopsy Evaluation of potentially clinically significant prostate cancer) multicentre randomised controlled trial .

Erickson A, Berglund E, He M, Marklund M, Mirzazadeh R, Schultz N, Bergenstråhle L, Kvastad L et al. . The spatial landscape of clonal somatic mutations in benign and malignant tissue .

Sjoberg HT, Philippou Y, Magnussen AL, Tullis ID, Bridges E, Chatrian A, Loefebvre J, Tam KH et al. . Tumor irradiation combined with vascular-targeted photodynamic therapy enhances anti-tumor effects in preclinical prostate cancer .